CD62L targeted antibody therapy (University of Queensland Diamantina Institute)
N/A
Report date: 2025/03/19 20:00:56
Base Information
Drug NameCD62L targeted antibody therapy (University of Queensland Diamantina Institute)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniquest Pty LtdThe University Of Queensland
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A